Regenerative Medicine Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Regenerative Medicine stocks.

Regenerative Medicine Stocks Recent News

Date Stock Title
May 3 ABBV Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
May 3 ABBV Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
May 3 AXGN AxoGen First Quarter 2024 Earnings: Misses Expectations
May 3 AXGN Axogen Inc (AXGN) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amidst Challenges
May 2 ABBV Top 25 Stocks in the S&P 500 by Index Weight Right Now
May 2 BLFS BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
May 2 AXGN AxoGen (AXGN) Reports Q1 Loss, Lags Revenue Estimates
May 2 LSTA Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024
May 2 AXGN AxoGen Non-GAAP EPS of -$0.06 beats by $0.01, revenue of $41.4M misses by $0.65M
May 2 AXGN Axogen, Inc Reports First Quarter 2024 Financial Results
May 2 ABBV The top pharmaceutical companies by R&D expenditure
May 1 LSTA Lisata Therapeutics files for $150M mixed securities shelf
May 1 ABBV BeiGene, AbbVie patent spat to get trial from USPTO appeals board
May 1 AXGN AxoGen Q1 2024 Earnings Preview
May 1 ABBV CVS stock plunges after earnings numbers one analyst 'did not even believe'
May 1 AXGN AxoGen, Inc. (NASDAQ:AXGN) is largely controlled by institutional shareholders who own 58% of the company
May 1 BCDA BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
Apr 30 BRTX BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Apr 30 BLFS BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
Apr 30 ABBV Trials to watch: Four ALS drugs to keep an eye on
Regenerative Medicine

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.Regenerative medicine also includes the possibility of growing tissues and organs in the laboratory and implanting them when the body cannot heal itself. If a regenerated organ's cells would be derived from the patient's own tissue or cells, this would potentially solve the problem of the shortage of organs available for donation, and the problem of organ transplant rejection.Some of the biomedical approaches within the field of regenerative medicine may involve the use of stem cells. Examples include the injection of stem cells or progenitor cells obtained through directed differentiation (cell therapies); the induction of regeneration by biologically active molecules administered alone or as a secretion by infused cells (immunomodulation therapy); and transplantation of in vitro grown organs and tissues (tissue engineering).

Browse All Tags